---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-002685"
form_type: "8-K"
ticker: "AXSM"
cik: "0001579428"
company_name: "Axsome Therapeutics, Inc."
filed_at: "2024-01-08T23:59:59+00:00"
generated_at: "2026-06-07T02:17:25.813946+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# Axsome updates corporate presentation; no financial details disclosed in filing

## Summary
- Axsome Therapeutics filed an 8-K on Jan 8, 2024, to announce an updated corporate presentation.
- The presentation was posted to the company's website and filed as Exhibit 99.1.
- No specific content, financial results, or guidance were provided in the filing.
- Investors should refer to the full presentation on Axsome's website for details.

## SEC filing metadata
- accession: 0000950170-24-002685
- form_type: 8-K
- ticker: AXSM
- cik: 0001579428
- company_name: Axsome Therapeutics, Inc.
- filed_at: 2024-01-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1579428/000095017024002685/0000950170-24-002685-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1579428/000095017024002685/axsm-20240108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-002685
- JSON: https://secwatch.observer/filing/0000950170-24-002685.json
- Plain text: https://secwatch.observer/filing/0000950170-24-002685.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.